Treace Medical Concepts, Inc.
TMCI
$5.34
-$0.03-0.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -52.99M | -55.74M | -61.52M | -63.68M | -54.75M |
| Total Depreciation and Amortization | 7.97M | 7.42M | 7.45M | 6.86M | 5.84M |
| Total Amortization of Deferred Charges | 1.30M | 1.30M | 797.00K | 798.00K | 798.00K |
| Total Other Non-Cash Items | 37.26M | 35.29M | 30.78M | 29.09M | 23.92M |
| Change in Net Operating Assets | -19.29M | -25.43M | -9.94M | -3.16M | -347.00K |
| Cash from Operations | -25.75M | -37.17M | -32.43M | -30.10M | -24.54M |
| Capital Expenditure | -11.21M | -11.59M | -10.77M | -11.41M | -13.91M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | -20.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 40.93M | 46.97M | 47.73M | 47.20M | 36.85M |
| Cash from Investing | 29.72M | 35.38M | 36.96M | 35.80M | 2.94M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 495.00K | 428.00K | 549.00K | 8.20M | 7.89M |
| Repurchase of Common Stock | -432.00K | -268.00K | -250.00K | -250.00K | -6.57M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -7.50M | 0.00 |
| Cash from Financing | 63.00K | 160.00K | 299.00K | 450.00K | 1.32M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.04M | -1.63M | 4.83M | 6.15M | -20.28M |